The company’s annual meeting resulted in the election of directors, ratification of an accounting firm, and approval of the reverse stock split amendment. More about Conduit Pharmaceuticals YTD ...

We currently have no CDT Stock Split History on this stock.

Peter Fuhr of Oak Ridge National Laboratory discusses the evolution of drones in the electric utility industry and the latest research in this two-part podcast series. Part 1 of the narrated version ...

SYMVESS, or the ATEV™, is a first-in-class bioengineered human tissue that is designed to be a universally implantable vascular conduit for use in arterial replacement and repair. While ...

Conduit Pharmaceuticals Inc. (NASDAQ:CDT), a Delaware-based pharmaceutical company ... In an attempt to address the issue, stockholders at the company's annual meeting held on Wednesday approved an ...

The Office of the Governor, in partnership with the Virgin Islands Department of Education’s State Office of Career, Technical, and Adult Education and the Virgin Islands Energy Office, is excited to ...

Benjamin Preston has been a reporter with the Consumer Reports autos team since 2020, focusing on new and used car buying, auto insurance, car maintenance and repair, and electric bikes.

GoodReturns is your trusted source for the latest financial news, investment insights, and expert guidance. Stay updated and make informed decisions with our comprehensive updates.